PATENT CLAIM ANALYSIS

Application Number: 16118376
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["544", "353000"]

Abstract:
A heterocyclic compound represented by the general formula (1) or a salt thereof: wherein m, l, and n respectively represent an integer of 1 or 2; X represents —O— or —CH 2 —; R 1  represents hydrogen, a lower alkyl group, a hydroxy-lower alkyl group, a protecting group, or a tri-lower alkylsilyloxy-lower alkyl group; R 2  and R 3 , which are the same or different, each independently represent hydrogen or a lower alkyl group; or R 2  and R 3  are bonded to form a cyclo-C3-C8 alkyl group; and R 4  represents an aromatic group or a heterocyclic group, wherein the aromatic or heterocyclic group may have one or more arbitrary substituent(s).

Claim (Index 6):
The method according to  claim 1 , wherein in the compound represented by the formula (1) or a pharmaceutically acceptable salt thereof is selected from (4aS,8aR)-1-(4-chlorophenyl)-3,3-dimethyldecahydroquinoxaline, 2-chloro-4-((4aS,8aS)-3,3-dimethyloctahydroquinoxalin-1(2H)-yl)benzonitrile, (4aS,8aR)-1-(3-chloro-4-fluorophenyl)-3,3-dimethyldecahydroquinoxaline, (4aS,8aR)-1-(7-fluorobenzofuran-4-yl)-3,3-dimethyldecahydroquinoxaline, 5-((4aR,8aS)-3,3-dimethyloctahydroquinoxalin-1(2H)-yl)-1-methyl-1H-indole-2-carbonitrile, (4a\u2032R,8a\u2032S)-4\u2032-(7-methoxybenzofuran-4-yl)octahydro-1 1 H-spiro[cyclobutane-1,2\u2032-quinoxaline], (4aS,8aR)-1-(6,7-difluorobenzofuran-4-yl)-3,3-dimethyldecahydroquinoxaline, 5-((4aS,8aS)-3,3-dimethyloctahydroquinoxalin-1 (2H)-yl)-1H-indole-2-carbonitrile, (4aS,8aR)-1-(7-chloro-2,3-dihydro-1H-inden-4-yl)-3,3-dimethyldecahydroquinoxaline, 6-((4aS,8aS)-3,3-dimethyloctahydroquinoxalin-1(2H)-yl)-2-naphthonitrile, (4aS,8aS)-3,3-dimethyl-1-(1H-pyrrolo[2,3-b]pyridin-4-yl)decahydroquinoxaline, and (4aS,8aS)-1-(4-(difluoromethoxy)-3-fluorophenyl)-3,3-dimethyldecahydroquinoxaline, (4aS,8aS)-1-(4-(difluoromethoxy)phenyl-3,3-dimethyldecahydroquinoxaline, and (4aR,8aR)-1-(4-difluoromethyoxy)-3-fluorophenyl-3,3-dimethyldecahydroquinoxaline.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 2.07812
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13822589', '15495862', '11991146', '13270544', '13388442']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7831800595327346
- 35 USC 102 Novelty (BERT): 0.596311183281259
- Combined Prediction Score: 0.7644931719075871
- Mean Citation Score: 383.689886
- Max Citation Score: 503.9384
- Similarity Product: 467.2278147659302

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test